Myopia Management
Myopic progression is when prescriptions increase over time, and higher prescriptions have been linked to
sight-threatening conditions later in life such as retinal detachment, glaucoma and myopic maculopathy.
Even children with fairly low prescriptions have a higher risk of glaucoma and retinal detachment compared to non-myopic children, and that risk multiplies as their prescriptions get stronger.
81% of eye care professionals agree that myopia is one of the biggest problems impacting children’s eyesight today. But until now, traditional eyeglasses and contact lenses available in the U.S. have only been developed to correct blurred vision, but they do nothing to help slow gradual prescription increases.
MiSight® 1 day is an award-winning dual-focus soft contact lens that uses ActivControl™ Technology to slow the elongation of the eyeball. The ActivControl™ Technology in MiSight® 1 day utilizes an optic zone concentric ring design with alternating vision correction and treatment zones. Two zones are vision correction zones with the label power of the contact lens, and the alternating two zones are treatment zones with 2 diopters of defocus to slow the progression of myopia.
CooperVision undertook a rigorous, multi-year, multi-country study to track how the MiSight® 1 day contact lens affected myopia progression when initially fit on children ages 8–12 years old. After three years, the study concluded the lens effectively slowed myopia progression by 59% and slowed the rate at which the eye lengthens by 52% compared to children in the control group wearing a single-vision 1-day lens.
Your MiSight® Lens Myopia Control Program includes the following:
• Evaluation and training by one of our trained doctors
• All related testing (refraction, topography, dilation, etc.)
• Bi-annual follow-ups to monitor for myopic changes
• 1-year supply of contact lenses
sight-threatening conditions later in life such as retinal detachment, glaucoma and myopic maculopathy.
Even children with fairly low prescriptions have a higher risk of glaucoma and retinal detachment compared to non-myopic children, and that risk multiplies as their prescriptions get stronger.
81% of eye care professionals agree that myopia is one of the biggest problems impacting children’s eyesight today. But until now, traditional eyeglasses and contact lenses available in the U.S. have only been developed to correct blurred vision, but they do nothing to help slow gradual prescription increases.
MiSight® 1 day is an award-winning dual-focus soft contact lens that uses ActivControl™ Technology to slow the elongation of the eyeball. The ActivControl™ Technology in MiSight® 1 day utilizes an optic zone concentric ring design with alternating vision correction and treatment zones. Two zones are vision correction zones with the label power of the contact lens, and the alternating two zones are treatment zones with 2 diopters of defocus to slow the progression of myopia.
CooperVision undertook a rigorous, multi-year, multi-country study to track how the MiSight® 1 day contact lens affected myopia progression when initially fit on children ages 8–12 years old. After three years, the study concluded the lens effectively slowed myopia progression by 59% and slowed the rate at which the eye lengthens by 52% compared to children in the control group wearing a single-vision 1-day lens.
Your MiSight® Lens Myopia Control Program includes the following:
• Evaluation and training by one of our trained doctors
• All related testing (refraction, topography, dilation, etc.)
• Bi-annual follow-ups to monitor for myopic changes
• 1-year supply of contact lenses
